Skip to main content
logo
Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
30.03
+0.62 (2.11%)
Nov 9, 2026, 10:43 AM EST - Market open

Agios Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
140.8454.0336.526.8214.24-
Revenue Growth
214.44%48.03%36.07%88.36%--
Gross Profit
-211.32-291.85-268.95-271.58-267.37-256.97
Operating Income
-419.32-472.13-425.74-391.49-389.05-378.42
Net Income
-372.9-412.78673.73-352.09-231.81,605
Earnings Per Share
-6.31-7.1211.64-6.33-4.2326.55
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
907.021,1641,532806.361,0971,286
Total Debt
26.5340.2156.997285.6697.09
Net Cash (Debt)
880.491,1241,475734.371,0111,189
Net Cash Growth
-27.39%-23.78%100.86%-27.39%-14.96%110.37%
Net Cash Per Share
14.9019.3925.4813.2018.4619.67

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-331.68-372.98-389.84-296.06-309.48-407.32
Capital Expenditures
-4.28-4.32-1.69-1-4.88-5.74
Free Cash Flow
-335.97-377.29-391.53-297.06-314.36-413.06
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-150.04%-----
Operating Margin
-297.72%-873.87%-1166.47%-1459.52%-2732.07%-
Pretax Margin
-265.48%-765.89%1967.15%-1312.63%-1627.82%-
Profit Margin
-264.76%-764.01%1845.92%-1312.63%-1627.82%-
FCF Margin
-238.54%-698.33%-1072.73%-1107.49%-2207.58%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.78--1.11
Forward PE
-7.847.84---
PS Ratio
12.4929.3851.3546.40108.35-